Merck & Co Financials

Merck & Co Inc

MRKNYSE

Trade with Public

$149.54

-3.56-2.33%

가까이에: Aug 27, 5:00 PM EST

$149.60

0.060.04%

시간외: 7:54 PM EST

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 주식 보고서

Merck & Co Financials

Merck & Co (MRK) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Launches 'Operation Economic Fury' on Iran— BULL, WMT, MRK Stock in Focus

U.S. stock futures were lower on Thursday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Wednesday’s higher close. President Donald Trump announced a harsh economic offensive against Iran

Rishabh Mishra

Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today

Treasury's expanded long-bond buybacks knocked yields off 20-month highs and sank the dollar, as gold soars.

Piero Cingari

Why Merck Just Slashed Its Profit Outlook By Nearly 50%

Merck cuts FY2026 adjusted EPS outlook nearly in half to $2.66-$2.76, citing $2.43/share in charges from its Terns acquisition.

Vandana Singh

PRO
Merck & Co Lowers FY2026 Adj EPS Guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 Est; Raises FY2026 Sales Guidance from $65.800B-$67.000B to $66.300B-$67.300B vs $66.802B Est

Merck & Co (NYSE:MRK) lowers FY2026 Adj EPS guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 analyst estimate. Raises FY2026 sales outlook from $65.800 billion-$67.000 billion to $66.300 billion-$67.300 billion vs

Benzinga Newsdesk

PRO
Merck & Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate

Merck & Co (NYSE:MRK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 106.1 percent decrease over earnings of $2.13 per share from the

Benzinga Newsdesk

Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier

Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook amid strong AI & diagnostic demand.

Lekha Gupta

Merck & Co Inc

Merck & Co Financials

Earnings & Guidance News

Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Launches 'Operation Economic Fury' on Iran— BULL, WMT, MRK Stock in Focus

Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today

Why Merck Just Slashed Its Profit Outlook By Nearly 50%

PRO
Merck & Co Lowers FY2026 Adj EPS Guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 Est; Raises FY2026 Sales Guidance from $65.800B-$67.000B to $66.300B-$67.300B vs $66.802B Est

PRO
Merck & Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate

Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier

뉴스

파트너 / 기고자

벤징가 글로벌

Benzinga

Benzinga

Benzinga

Merck & Co Inc

Merck & Co Financials

Earnings & Guidance News

Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Launches 'Operation Economic Fury' on Iran— BULL, WMT, MRK Stock in Focus

Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today

Why Merck Just Slashed Its Profit Outlook By Nearly 50%

PROMerck & Co Lowers FY2026 Adj EPS Guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 Est; Raises FY2026 Sales Guidance from $65.800B-$67.000B to $66.300B-$67.300B vs $66.802B Est

PROMerck & Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate

Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier

Benzinga

뉴스

파트너 / 기고자

벤징가 글로벌

PRO
Merck & Co Lowers FY2026 Adj EPS Guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 Est; Raises FY2026 Sales Guidance from $65.800B-$67.000B to $66.300B-$67.300B vs $66.802B Est

PRO
Merck & Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate